141 related articles for article (PubMed ID: 1425314)
1. [The pharmacokinetics and bioavailability of acepromazine in the plasma of dogs].
Hashem A; Kietzmann M; Scherkl R
Dtsch Tierarztl Wochenschr; 1992 Oct; 99(10):396-8. PubMed ID: 1425314
[TBL] [Abstract][Full Text] [Related]
2. Disposition, bioavailability and clinical efficacy of orally administered acepromazine in the horse.
Hashem A; Keller H
J Vet Pharmacol Ther; 1993 Sep; 16(3):359-68. PubMed ID: 8230407
[TBL] [Abstract][Full Text] [Related]
3. Analytical determination and pharmacokinetics of robenacoxib in the dog.
Jung M; Lees P; Seewald W; King JN
J Vet Pharmacol Ther; 2009 Feb; 32(1):41-8. PubMed ID: 19161454
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of florfenicol and its metabolite, florfenicol amine, in dogs.
Park BK; Lim JH; Kim MS; Hwang YH; Yun HI
Res Vet Sci; 2008 Feb; 84(1):85-9. PubMed ID: 17570454
[TBL] [Abstract][Full Text] [Related]
5. Bioavailability and pharmacokinetics of intravenously and orally administered allopurinol in healthy beagles.
Bartges JW; Osborne CA; Felice LJ; Koehler LA; Ulrich LK; Bird KA; Chen M; Sawchuk RJ
Am J Vet Res; 1997 May; 58(5):504-10. PubMed ID: 9140559
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of oral morphine sulfate in dogs: a comparison of sustained release and conventional formulations.
Dohoo SE; Tasker RA
Can J Vet Res; 1997 Oct; 61(4):251-5. PubMed ID: 9342447
[TBL] [Abstract][Full Text] [Related]
7. The comparative plasma pharmacokinetics of intravenous cefpodoxime sodium and oral cefpodoxime proxetil in beagle dogs.
Brown SA; Boucher JF; Hubbard VL; Prough MJ; Flook TF
J Vet Pharmacol Ther; 2007 Aug; 30(4):320-6. PubMed ID: 17610405
[TBL] [Abstract][Full Text] [Related]
8. Clinical pharmacokinetics of phenytoin in the dog: a reevaluation.
Frey HH; Löscher W
Am J Vet Res; 1980 Oct; 41(10):1635-8. PubMed ID: 6784613
[TBL] [Abstract][Full Text] [Related]
9. The absolute oral bioavailability of dapsone in dogs and humans.
Pieters FA; Zuidema J
Int J Clin Pharmacol Ther Toxicol; 1987 Jul; 25(7):396-400. PubMed ID: 3623744
[TBL] [Abstract][Full Text] [Related]
10. Levamisole pharmacokinetics and bioavailability in dogs.
Watson AD; Sangster NC; Church DB; Van Gogh H
Res Vet Sci; 1988 Nov; 45(3):411-3. PubMed ID: 3212292
[TBL] [Abstract][Full Text] [Related]
11. The effects of inhibiting cytochrome P450 3A, p-glycoprotein, and gastric acid secretion on the oral bioavailability of methadone in dogs.
Kukanich B; Lascelles BD; Aman AM; Mealey KL; Papich MG
J Vet Pharmacol Ther; 2005 Oct; 28(5):461-6. PubMed ID: 16207309
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of probenecid and the effect of oral probenecid administration on the pharmacokinetics of cefazolin in mares.
Donecker JM; Sams RA; Ashcraft SM
Am J Vet Res; 1986 Jan; 47(1):89-95. PubMed ID: 3946913
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics of norfloxacin in dogs after single intravenous and single and multiple oral administrations of the drug.
Brown SA; Cooper J; Gauze JJ; Greco DS; Weise DW; Buck JM
Am J Vet Res; 1990 Jul; 51(7):1065-70. PubMed ID: 2389884
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
16. Plasma profile and pharmacokinetics of dextromethorphan after intravenous and oral administration in healthy dogs.
Kukanich B; Papich MG
J Vet Pharmacol Ther; 2004 Oct; 27(5):337-41. PubMed ID: 15500572
[TBL] [Abstract][Full Text] [Related]
17. Disposition and safety of zonisamide after intravenous and oral single dose and oral multiple dosing in normal hound dogs.
Boothe DM; Perkins J
J Vet Pharmacol Ther; 2008 Dec; 31(6):544-53. PubMed ID: 19000278
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics of luxabendazole after oral and intravenous administration to sheep.
Ortiz AI; Alvarez-Bujidos L; Ferre I; Ordóñez D
Am J Vet Res; 1997 Nov; 58(11):1263-6. PubMed ID: 9361890
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
Sakashita M; Mizuki Y; Yamaguchi T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
[TBL] [Abstract][Full Text] [Related]
20. Pharmacodisposition of thiamphenicol in rabbits.
Abd El-Aty AM; Abo El Sooud K; Goudah AM
Dtsch Tierarztl Wochenschr; 2001 Sep; 108(9):393-6. PubMed ID: 11599443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
